Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Mining gains offset by falls from airline, healthcare stocks

Tue, 07th Oct 2014 11:36

Poor economic data was weighing on UK stocks on Tuesday, with decent gains in the mining sector offset by falls from airlines and pharmaceuticals.The FTSE 100 was trading 0.6% lower at 6,522 by around midday.Nervousness ahead of the start of third-quarter earnings season in the States was also causing investors to tread cautiously, with US stock futures trading firmly lower ahead of the opening bell.German, UK industrial productionEconomic news wasn't helping sentiment in early deals after it was revealed that German industrial production dropped by 4% in August, pulling back after a revised 1.6% increase in July. The consensus estimate was for a lesser decline of 1.5%.The figures followed further weak figures from Germany on Monday which showed that factory orders in August slumped 5.7% after 4.9% growth in July. This was the biggest slump since 2009.Closer to home, UK industrial production was flat in August after a 0.4% expansion in July, though this was in line with estimates.Analysts at Capital Economics said that the industrial recovery in Britain is "still lacking momentum" and the data showed that the economic recovery "remained unbalanced in the third quarter".Rio Tinto jumps after Glencore approach revealedRio Tinto rose strongly after confirming that Glencore had approached the company in July about a "possible combination", though the board had rejected the approach as it "was not in the best interests of [...] shareholders".Rio Tinto was responding to press speculation after Bloomberg earlier said that Glencore was in talks with Rio Tinto's biggest shareholder, Chinalco, to gauge its interest in a potential deal. These discussions had taken place in recent weeks, sources said.Others in the sector were also on the rise, including Antofagasta, Randgold Resources and Centamin. Antofagasta was given a lift by an upgrade to 'neutral' by Nomura.However, leading the downside were airlines Easyjet and IAG after a strong performance the previous session, with the latter especially hit by the news of a person contracting the Ebola virus in Spain.Pharmaceuticals were also under the weather after Morgan Stanley cut its rating on the European healthcare sector to 'underweight'. Astrazeneca, Glaxosmithkline and Shire were all lower.Tesco was continuing to recover after its recent slump after having asked another member of its senior management to step down in the wake of an investigation into accounting practices. The company was also reportedly contacted by private equity buyout company TPG about potentially acquiring Dunnhumby, the data analysis unit that runs its Clubcard loyalty scheme.Oil and gas group Cairn Energy was a high riser on the FTSE 250 after discovering oil at its FAN-1 exploration well offshore Senegal, causing shares to surge. The find "materially upgrades the prospectivity" of the Sangomar Deep Block, the company said.However, telecoms tester Spirent Communications saw shares sink after it warned that revenues and profits in the second half would be lower than previously guided due to lower demand in the US and China.Market MoverstechMARK 2,757.48 -1.27%FTSE 100 6,522.39 -0.63%FTSE 250 15,144.22 -0.87%FTSE 100 - RisersRio Tinto (RIO) 3,139.50p +4.75%Tesco (TSCO) 182.30p +3.14%Anglo American (AAL) 1,377.50p +2.19%Randgold Resources Ltd. (RRS) 4,200.00p +1.13%Standard Chartered (STAN) 1,140.50p +1.02%Admiral Group (ADM) 1,299.00p +0.70%Aberdeen Asset Management (ADN) 395.50p +0.64%Antofagasta (ANTO) 710.00p +0.50%Sports Direct International (SPD) 616.50p +0.41%Coca-Cola HBC AG (CDI) (CCH) 1,331.00p +0.30%FTSE 100 - FallersInternational Consolidated Airlines Group SA (CDI) (IAG) 349.70p -5.82%easyJet (EZJ) 1,400.00p -4.57%Carnival (CCL) 2,400.00p -3.81%Schroders (SDR) 2,287.00p -2.72%InterContinental Hotels Group (IHG) 2,271.00p -2.49%TUI Travel (TT.) 388.20p -2.29%London Stock Exchange Group (LSE) 1,821.00p -1.94%Ashtead Group (AHT) 995.00p -1.78%Petrofac Ltd. (PFC) 965.00p -1.78%Whitbread (WTB) 4,067.00p -1.76%FTSE 250 - RisersCairn Energy (CNE) 194.30p +8.00%Tullett Prebon (TLPR) 265.60p +2.55%Zoopla Property Group (WI) (ZPLA) 219.60p +1.34%Centamin (DI) (CEY) 58.60p +1.30%Lonmin (LMI) 170.00p +1.25%Countrywide (CWD) 471.60p +1.20%Merlin Entertainments (MERL) 348.70p +0.87%Kazakhmys (KAZ) 252.00p +0.72%Ted Baker (TED) 2,013.00p +0.65%Hikma Pharmaceuticals (HIK) 1,770.00p +0.51%FTSE 250 - FallersSpirent Communications (SPT) 79.70p -19.21%Just Retirement Group (JRG) 120.90p -4.28%Thomas Cook Group (TCG) 114.50p -3.78%Hunting (HTG) 846.00p -3.42%Fidessa Group (FDSA) 2,236.00p -3.20%EnQuest (ENQ) 99.85p -2.96%Enterprise Inns (ETI) 118.10p -2.88%Telecity Group (TCY) 713.50p -2.86%Spirax-Sarco Engineering (SPX) 2,759.00p -2.41%Big Yellow Group (BYG) 498.70p -2.41%
More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.